We are live on ! Find out more
BUDX

Cannabis Growth ETF

Delisted

BUDX was delisted on the 25th of April, 2022.

2 hedge funds and large institutions have $13K invested in Cannabis Growth ETF in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less funds holding

Funds holding: 32 (-1)

98% less capital invested

Capital invested by funds: $660K → $13K (-$647K)

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$2.77K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$11K +$2.77K +237 +33%
Osaic Holdings
2
Osaic Holdings
Arizona
$2K

BUDX Hedge Fund Activity: Q1 2022 in Review

2 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Cannabis Growth ETF (BUDX) for Q1 2022, worth a combined $13K — down 98% from $660K a quarter earlier.

Fund positioning in BUDX was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $2.77K.

  • 2 institutional investors held Cannabis Growth ETF (BUDX) as of Q1 2022, down from 3 in Q4 2021.
  • Funds reported $13K of Cannabis Growth ETF stock for Q1 2022, down 98% quarter-over-quarter.
  • 0 funds opened new Cannabis Growth ETF positions in Q1 2022 and 0 closed out.
  • The largest Cannabis Growth ETF buyer in Q1 2022 was UBS Group, an estimated $2.77K added.

Based on aggregated 13F filings for Q1 2022.